{"id":446503,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2023-06-23] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:06:35.077000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2023-06-23.html?wbdisable=false","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2023-06-23] June 23, 2023 Our file number: 23-105485-620 The purpose of this Notice of Amendment is to notify about the addition of concizumab, daridorexant, foscarbidopa, foslevodopa, glofitamab, setmelanotide,…","rawSnapshotUrl":"/api/snapshots/raw/446503","browseUrl":"https://replay.healtharchive.ca/job-6/20260103120635/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2023-06-23.html?wbdisable=false#ha_snapshot=446503","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}